China SXT Pharmaceuticals annual operating expenses
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
China SXT Pharmaceuticals Operating Expenses Growth & History (SXTC)
China SXT Pharmaceuticals's operating expenses was $7.4M for fiscal 2026.
View full China SXT Pharmaceuticals company overviewChina SXT Pharmaceuticals annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-03-31 | $7.4M | $4.3M | +141.86% |
| 2025 | 2025-03-31 | $3.0M | −$21,282 | −0.69% |
| 2024 | 2024-03-31 | $3.1M | −$3.0M | −49.13% |
| 2023 | 2023-03-31 | $6.0M | −$407,536 | −6.33% |
| 2022 | 2022-03-31 | $6.4M | $1.4M | +27.89% |
| 2021 | 2021-03-31 | $5.0M | $991,807 | +24.52% |
| 2020 | 2020-03-31 | $4.0M | $1.2M | +42.32% |
| 2019 | 2019-03-31 | $2.8M | $1.1M | +60.64% |
| 2018 | 2018-03-31 | $1.8M | $1.1M | +149.25% |
| 2017 | 2017-03-31 | $709,819 | — | — |
China SXT Pharmaceuticals operating expenses trends
Over the last five fiscal years, China SXT Pharmaceuticals's operating expenses increased from $5.0M to $7.4M, a change of $2.3M.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review China SXT Pharmaceuticals source filings ↗